Bristol, United Kingdom

Anna Katharina Mellor

This inventor holds 1 USPTO granted patent. Top assignee: Vationpharma B.v.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Katharina Mellor. Retrieved from https://idiyas.com/inventor/anna-katharina-mellor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Anna Katharina Mellor

Introduction

Anna Katharina Mellor is an accomplished inventor based in Bristol, GB. She has made significant contributions to the field of pharmaceuticals, particularly with her work on oclacitinib maleate. Her innovative approach has led to the development of solid state forms of this compound, which are crucial for enhancing its efficacy and stability.

Latest Patents

Anna holds 1 patent for her invention titled "Solid state forms of oclacitinib maleate." This patent relates to various solid state forms of oclacitinib maleate and methods for their preparation. The solid state forms include amorphous oclacitinib maleate, crystalline tetramethyl urea solvate form, crystalline monohydrate form, and crystalline form B of oclacitinib maleate. These advancements are essential for improving the therapeutic applications of the drug.

Career Highlights

Anna is currently associated with Vationpharma B.V., where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to enhancing drug formulations and improving patient outcomes.

Collaborations

Anna collaborates with notable colleagues, including Bin Li and Analia Ivanna Chamorro Orue. These partnerships foster a dynamic environment for research and development, leading to groundbreaking advancements in their field.

Conclusion

Anna Katharina Mellor's contributions to the pharmaceutical industry through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in drug formulation and efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…